Request Trial
31 July 2025VideosAmericasSteve Trybus, Troutman Pepper Locke | Jennifer Burdman, Sauvegarder Investment Management | Elbert Chiang, Beam Therapeutics | Mark Jackson, Editas Med | Lillian Hiett, Takeda

WATCH: Beyond patents — the evolving role of IP lawyers in life sciences

This LSPN panel brings together experts from Troutman Pepper Locke, Sauvegarder Investment Management, Beam Therapeutics, Editas Med, and Takeda to explore the expanding role of IP lawyers in the life sciences industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Health tech firm sues Nvidia-backed rival over ‘brazen’ theft
23 April 2026   Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space.
Americas
Squires refuses to resurrect HydraFacial patent review
22 April 2026   Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges.
Americas
LSPN Awards USA: Meet the judges
10 April 2026   The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners.


Editor's picks

Penile implant maker’s $17m trade secret award unravels
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026

Editor's picks

Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026
Biotechnology
mRNA litigation: Who’s winning, who’s filing, and what’s next
25 March 2026
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

More features

Amneal acquires biopharma ahead of $300bn patent wave
Health tech firm sues Nvidia-backed rival over ‘brazen’ theft
Squires refuses to resurrect HydraFacial patent review
Litigator from Brown Rudnick moves firms to chair practice
INTA 2026: In-house tips on what to do in London
Penile implant maker’s $17m trade secret award unravels
Appeals court eases Teva’s headache with reversal
Cancer drug researcher hit with suit over mutation-targeting tools